Biotech News

LeMaitre Will Announce Fourth Quarter 2025 Earnings Results February 25, 2026

LeMaitre Vascular (LMAT)LeMaitre VascularEarnings

LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its fourth quarter 2025 financial results on Wednesday, February 25, 2026, after the market close. The company has scheduled a conference call for 5:00 PM EST the same day to discuss the results, business highlights, and company outlook.

Access to the live call is available by registering online here . All registrants will receive dial-in information and a PIN allowing them to access the live call. The audio webcast can also be accessed live or via replay at www.lemaitre.com/investor .

About LeMaitre

LeMaitre is a provider of devices, implants, and services for the treatment of peripheral vascular disease, a condition that affects more than 200 million people worldwide. The Company develops, manufactures, and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. Additional information can be found at www.lemaitre.com .

LeMaitre and the LeMaitre logo are registered trademarks of LeMaitre Vascular, Inc.

Related news

LeMaitre Vascular

LeMaitre Vascular is a medical device company serving vascular surgeons with implants, grafts, and related products. The business is rooted in procedure-linked vascular care.

Recent company news

Stock data

Close
81.86 USD
Market cap
2.09B USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States